Oral GLP-1 May Be Right for You If: If you prefer to avoid injections or are uncomfortable with needles
#Obesity #GLP1 #AstraZeneca #PharmaceuticalIndustry #ClinicalResearch #Innovation #CardiometabolicHealth #Healthcare #DrugDevelopment #LifeSciences AstraZeneca Expands into Obesity with Oral GLP-1 Therapy AstraZeneca Expands into the Obesity Space The obesity treatment landscape continues to evolve rapidly, and AstraZenecas positive Phase II results for its oral GLP-1 therapy represent an important milestone
PsA Disease Activity Improves on GLP-1s A retrospective study presented at ACR Convergence 2025, led by researchers from the University of Toronto and NYU, followed 48 patients with psoriatic arthritis who started GLP-1 receptor agonists. The findings: Significant weight loss (35% of patients lost 510% of body weight
Rao C, et al
Some sports bodies test for certain peptides and list them as banned
Common side effects may include: Nausea or stomach upset Constipation, diarrhea, or abdominal discomfort Fatigue or mild headache Dizziness or bloating Redness or tenderness at the injection site To minimize side effects: Eat slowly and stop when full Stay hydrated (aim for 1 gallon of water daily) Avoid greasy, fried, or sugary foods Limit alcohol intake Are GLP-1s safe